Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;44(1):120-5.
doi: 10.1016/j.jsat.2012.03.004. Epub 2012 Apr 25.

Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs

Amanda J Abraham  1 , Lauren A O'Brien, Hannah K Knudsen, Brian E Bride, G Rush Smith, Paul M Roman
Affiliations

Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs

Amanda J Abraham et al. J Subst Abuse Treat. 2013 Jan.

Abstract

Racial and ethnic minorities and injection drug users (IDUs) are at increased risk of HIV infection. However, the associations between these caseload characteristics and the availability of onsite HIV testing in substance use disorder treatment programs are unknown. This study uses data collected in 2008-2009 from 198 program administrators of treatment programs participating in the National Institute on Drug Abuse's Clinical Trials Network to address this gap in the literature. Results show positive associations between the percentages of African American, Hispanic, and IDU patients and the odds of offering non-rapid onsite HIV testing versus no onsite testing. The associations between racial/ethnic composition and the availability of rapid HIV testing were more complicated. These findings suggest that many programs are responding to the needs of at-risk populations. However, programs and their patients may benefit from greater adoption of rapid testing which is less costly and better ensures that patients receive their results.

PubMed Disclaimer

References

    1. Abraham AJ, Knudsen HK, Rothrauff TC, Roman PM. The adoption of alcohol pharmacotherapies in the Clinical Trials Network: The influence of research network participation. Journal of Substance Abuse Treatment. 2010;38:275–283. - PMC - PubMed
    1. Abraham AJ, O’Brien LA, Bride BE, Roman PM. HIV/AIDS services in private substance abuse treatment programs. Drug and Alcohol Dependence. 2011;115:16–22. - PMC - PubMed
    1. Bini EJ, Kritz S, Brown LS, Robinson J, Alderson D, Rotrosen J. Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States. Journal of Addictive Diseases. 2011;30:98–109. - PMC - PubMed
    1. Blower S, Gershengorn HB, Grant R. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science. 2000;287:650–654. - PubMed
    1. Branson BM. Rapid test for HIV antibody. AIDS Reviews. 2000;20:76–83.

Publication types

MeSH terms